Published August 17, 2026Updated October 30, 2026

How to Pay for a GLP-1 Without Insurance: Savings Cards, Self-Pay and Compounded

Getting semaglutide, tirzepatide and other GLP-1s without insurance: compounded options, manufacturer coupons, and the cheapest legal paths.

By Nora Bissett, Pricing Editor

Our methodology sets out how these guides get researched and kept current.

Looking for a provider? Our 2026 comparison of the leading GLP-1 telehealth sellers is a click away.

GLP-1 Savings Calculator →

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

If your insurance doesn't cover Wegovy, Zepbound, or any other GLP-1 weight-loss medication, you are not alone. Many commercially insured adults have no obesity-medication coverage at all, and Medicare has historically excluded weight-loss drugs from Part D coverage entirely (a temporary Medicare GLP-1 Bridge now opens a $50/month route for some Part D patients). In 2026 there are more legal, affordable paths to a GLP-1 than ever before, but choosing one means sorting through a confusing mix of compounding pharmacies, manufacturer coupons, and telehealth providers.

Below are the realistic options for getting a GLP-1 medication without insurance, from cheapest to most expensive, with the safety and legal caveats for each. For a personalized cost estimate, run your numbers through our GLP-1 savings calculator.

Key Takeaways

  • Compounded semaglutide via reputable telehealth providers is currently the cheapest legal path: $129–$249/month.
  • Manufacturer savings cards bring brand-name cost to as little as $25/month if your commercial plan covers the drug; where the plan does not cover Zepbound, its card brings the single-dose pen to $499/month.
  • Brand-name self-pay is now well below list: the Wegovy pill from $149/month and the Wegovy pen at $349/month through NovoCare Pharmacy, and Zepbound KwikPens or vials from $299/month through LillyDirect.
  • International pharmacies (Canadian, UK) are not legal for U.S. patients in most cases, so be very cautious.
  • Off-label Ozempic is harder to obtain in 2026 due to insurance audits and supply allocation.
  • Always verify your provider with LegitScript or state pharmacy board records before paying.

In 2026, the lowest-cost legal path to GLP-1 medication is compounded semaglutide or tirzepatide dispensed through a licensed telehealth provider. Pricing typically runs $129–$399/month depending on the drug, dose, and provider.

How it works

  1. You complete an online medical intake with a telehealth provider.
  2. A licensed prescriber (MD, NP, or PA) reviews your intake and, if appropriate, writes a prescription for compounded semaglutide or tirzepatide.
  3. The prescription is filled by a state-licensed 503A compounding pharmacy, which prepares it for you individually. (During the shortages, FDA-registered 503B outsourcing facilities also made these drugs in batches; FDA says they may no longer compound semaglutide or tirzepatide from bulk.)
  4. The medication ships to your door, usually with cold-chain packaging.

Why it's so much cheaper

Brand-name Wegovy and Zepbound carry list prices over $1,000/month because the manufacturers are recouping R&D and marketing costs and running a global supply chain. Compounding pharmacies source the active pharmaceutical ingredient (API) separately and produce smaller batches without the brand-name overhead. The cost per dose drops dramatically.

Top providers in 2026

From our best GLP-1 providers ranking:

Top providers in 2026
ProviderStarting priceDrug optionsNotes
CoreAge Rx$79/mo semaglutide, $129/mo tirzepatideSemaglutide + tirzepatideOne price at every dose
Henry Meds$297/moSemaglutide + tirzepatideEstablished, strong support
Mochi Health$79/mo (membership) + medicationSemaglutide, tirzepatideMore medical oversight
Found$289/mo month to month ($169/mo on a 12-month prepaid plan)Semaglutide + tirzepatideComprehensive program

Price comparison is easier at sellers that show the price before asking any medical questions. Spry, Teleios Health and BloomWell Rx list a starting compounded semaglutide price up front. Mint Medical Clinic and Clinic Secret also list compounded semaglutide and tirzepatide, and VevaRx publishes plan prices from month-to-month to 12 months, at one price across doses.

If you want to pay with pre-tax money, Klarity Health, a marketplace that routes patients to independent licensed providers, accepts HSA and FSA cards, and so does Lean Rx, whose compounded plans run a 24-week minimum. TRYM Health also lists FSA/HSA eligibility, though its sign-up page now says registrations are closed.

Safety considerations

Not all compounding pharmacies are equal. Before you sign up with any telehealth provider, verify:

  • The provider names a 503A pharmacy licensed in your state, which you can look up with your state board of pharmacy
  • The provider is LegitScript-certified
  • The medication ships in cold-chain packaging (semaglutide and tirzepatide both require refrigeration)
  • A licensed prescriber reviews your intake (not just an algorithm)

We cover red flags in detail in our compounded semaglutide safety guide. Read that before you commit to any compounded provider.

Option 2: Manufacturer Savings Cards

Both Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) operate savings programs that can dramatically reduce out-of-pocket costs.

Wegovy Savings Card (Novo Nordisk)

  • Commercially insured, with Wegovy coverage: as low as $25/month (savings capped at $100/month)
  • No Wegovy coverage, or paying cash: the card does not apply; Novo Nordisk's self-pay prices do (Option 3)
  • Not eligible: Medicare, Medicaid, VA/Tricare

Zepbound Savings Card (Eli Lilly)

  • Commercially insured, no Zepbound coverage: as low as $499/month for the single-dose pen
  • Commercially insured, with Zepbound coverage: as low as $25/month
  • Not eligible: Medicare, Medicaid, VA/Tricare

Both cards require *commercial* (non-government) insurance. The full terms and caps are in our manufacturer coupons guide.

If you are completely uninsured or on Medicare/Medicaid, you don't qualify for these savings cards, and Option 1 (compounded) or Option 3 (brand-name self-pay) will be your best bet. Medicare Part D patients who qualify can also get Wegovy, Foundayo or the Zepbound KwikPen for $50/month under the Medicare GLP-1 Bridge, which is temporary and runs until the end of 2027.

Option 3: Brand-Name Self-Pay (LillyDirect and NovoCare)

In 2024, Eli Lilly launched LillyDirect, a direct-to-consumer program offering Zepbound in single-dose vials at lower prices than the standard pre-filled pen; the multi-dose KwikPen is now sold at the same prices. Pricing in 2026 (list price is up to ~$1,086/month):

Option 3: Brand-Name Self-Pay (LillyDirect and NovoCare)
DoseLillyDirect cash price, refill within 45 daysIf a refill is later than 45 days
2.5 mg$299/month$299/month
5 mg$399/month$399/month
7.5 mg$449/month$499/month
10 mg$449/month$699/month
12.5 mg$449/month$699/month
15 mg$449/month$699/month

This is brand-name Zepbound, with the same FDA-approved formulation and package insert. Only the format differs: you self-administer with a syringe or the KwikPen rather than a single-dose pen.

Novo Nordisk sells Wegovy the same way through NovoCare Pharmacy: the pill ranges from $149 a month on the 1.5 mg dose up to $299 on 9 or 25 mg (4 mg is $199), and the pen costs $349/month ($399 for the 7.2 mg dose; new patients pay $199 apiece for their first two fills on 0.25 or 0.5 mg, through December 31, 2026).

For patients who want brand-name certainty without insurance, these self-pay programs are currently the best option. They usually still cost more than compounded medication, but they offer regulatory peace of mind.

Option 4: Insurance Appeal (If Marginal Coverage Exists)

If your insurance plan technically covers obesity drugs but denied your specific claim, an appeal is worth the effort. Successful appeals typically include:

  1. Documented BMI ≥30 (or ≥27 with comorbidity)
  2. Failed prior weight-loss attempts (commercial program records, prior medication trials)
  3. Letter of medical necessity from your prescriber
  4. Comorbidity documentation (sleep apnea, hypertension, prediabetes, etc.)

We keep a state-by-state breakdown of coverage in our research article on GLP-1 coverage across commercial plans, Medicaid and Medicare. To confirm your specific plan's coverage, call the number on your insurance card.

What to Avoid

International pharmacies

Canadian and UK pharmacies sell Ozempic, Wegovy, Mounjaro, and Zepbound at lower prices than U.S. retail. It is illegal for U.S. patients to import most of these medications for personal use, with very narrow exceptions. The FDA has explicitly warned against this practice. Aside from the legal risk, there is no way to verify cold-chain integrity for international shipping.

"Research peptides" sold online

Numerous websites sell semaglutide and tirzepatide as "research peptides" or "not for human use" products. These are unregulated, frequently mislabeled or contaminated, and have caused multiple cases of serious adverse events. The FDA has issued warning letters to several of these vendors. Do not buy from these sources.

Off-label Ozempic for weight loss

From 2021 to 2024, many patients without diabetes obtained off-label Ozempic prescriptions. In 2026, this is much harder: PBMs require lab documentation of diabetes for Ozempic claims, and the supply allocation has shifted to prioritize Wegovy for obesity indications. Trying to game the system is more trouble than it's worth.

Putting It All Together

For most uninsured or under-insured patients in 2026, the decision tree is:

  1. Does your commercial plan cover Wegovy or Zepbound? Use the maker's savings card first.
  2. No coverage, on Medicare or Medicaid, or completely uninsured? Choose between brand-name self-pay (Wegovy pill from $149/mo and pen $349/mo through NovoCare; Zepbound KwikPen or vials $299–$449/mo through LillyDirect) and compounded semaglutide via telehealth (~$129–$249/mo). Medicare Part D patients should check the Medicare GLP-1 Bridge first.
  3. Want the lowest possible cost? Compounded semaglutide via a verified telehealth provider, starting around $129/month.
  4. Want maximum regulatory certainty? Brand-name self-pay from LillyDirect or NovoCare.

Before committing to any path, plug your numbers into our GLP-1 savings calculator to see the apples-to-apples cost comparison for your specific situation. And read our compounded semaglutide safety guide before signing up with any telehealth provider. A $149/month plan can be a good deal or a $149/month problem, and the guide shows how to tell which.

For a deeper look at the brand-name landscape, see our Ozempic vs Wegovy guide.

Sources & methodology — as of October 2026
  1. 1.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  2. 2.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  3. 3.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  4. 4.NovoCare — Wegovy cash-pay and savings program— Novo Nordisk (NovoCare).
  5. 5.LillyDirect — Zepbound self-pay program and cash price— Eli Lilly and Company (LillyDirect).
  6. 6.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  7. 7.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.

Ready to compare GLP-1 providers?

Trust, support, availability, the medications carried and what they cost — we rank every major telehealth seller on all five, and refresh it each quarter. Nothing padded.

GLP-1 Savings Calculator →

Read our methodology · affiliate disclosure · about us